347 related articles for article (PubMed ID: 22071603)
1. Up-regulation of microRNA-155 promotes cancer cell invasion and predicts poor survival of hepatocellular carcinoma following liver transplantation.
Han ZB; Chen HY; Fan JW; Wu JY; Tang HM; Peng ZH
J Cancer Res Clin Oncol; 2012 Jan; 138(1):153-61. PubMed ID: 22071603
[TBL] [Abstract][Full Text] [Related]
2. Identification of recurrence-related microRNAs in hepatocellular carcinoma following liver transplantation.
Han ZB; Zhong L; Teng MJ; Fan JW; Tang HM; Wu JY; Chen HY; Wang ZW; Qiu GQ; Peng ZH
Mol Oncol; 2012 Aug; 6(4):445-57. PubMed ID: 22552153
[TBL] [Abstract][Full Text] [Related]
3. Decrease expression of microRNA-20a promotes cancer cell proliferation and predicts poor survival of hepatocellular carcinoma.
Fan MQ; Huang CB; Gu Y; Xiao Y; Sheng JX; Zhong L
J Exp Clin Cancer Res; 2013 Apr; 32(1):21. PubMed ID: 23594563
[TBL] [Abstract][Full Text] [Related]
4. [Expression and survival prediction of microRNA-155 in hepatocellular carcinoma after liver transplantation].
Han ZB; Chen HY; Fan JW; Wu JY; Peng ZH; Wang ZW
Zhonghua Yi Xue Za Zhi; 2013 Mar; 93(12):884-7. PubMed ID: 23863669
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of miR-21 predicts poor prognosis in patients with hepatocellular carcinoma.
Huang CS; Yu W; Cui H; Wang YJ; Zhang L; Han F; Huang T
Int J Clin Exp Pathol; 2015; 8(6):7234-8. PubMed ID: 26261620
[TBL] [Abstract][Full Text] [Related]
6. Early-phase circulating miRNAs predict tumor recurrence and survival of hepatocellular carcinoma patients after liver transplantation.
Ng KT; Lo CM; Wong N; Li CX; Qi X; Liu XB; Geng W; Yeung OW; Ma YY; Chan SC; Man K
Oncotarget; 2016 Apr; 7(15):19824-39. PubMed ID: 26918346
[TBL] [Abstract][Full Text] [Related]
7. miR-203 expression predicts outcome after liver transplantation for hepatocellular carcinoma in cirrhotic liver.
Chen HY; Han ZB; Fan JW; Xia J; Wu JY; Qiu GQ; Tang HM; Peng ZH
Med Oncol; 2012 Sep; 29(3):1859-65. PubMed ID: 21786180
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of microRNA-372 associates with tumor progression and prognosis in hepatocellular carcinoma.
Gu H; Guo X; Zou L; Zhu H; Zhang J
Mol Cell Biochem; 2013 Mar; 375(1-2):23-30. PubMed ID: 23291979
[TBL] [Abstract][Full Text] [Related]
9. Post-transplant infection improves outcome of hepatocellular carcinoma patients after orthotopic liver transplantation.
Chao JS; Zhao SL; Ou-Yang SW; Qian YB; Liu AQ; Tang HM; Zhong L; Peng ZH; Xu JM; Sun HC
World J Gastroenterol; 2019 Oct; 25(37):5630-5640. PubMed ID: 31602163
[TBL] [Abstract][Full Text] [Related]
10. A microRNA biomarker of hepatocellular carcinoma recurrence following liver transplantation accounting for within-patient heterogeneity.
Xie QY; Almudevar A; Whitney-Miller CL; Barry CT; McCall MN
BMC Med Genomics; 2016 Apr; 9():18. PubMed ID: 27059462
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of microRNA-106b is associated with poor prognosis in hepatocellular carcinoma.
Li BK; Huang PZ; Qiu JL; Liao YD; Hong J; Yuan YF
Diagn Pathol; 2014 Dec; 9():226. PubMed ID: 25466449
[TBL] [Abstract][Full Text] [Related]
12. miR-106b-5p promotes aggressive progression of hepatocellular carcinoma via targeting RUNX3.
Gu H; Gu S; Zhang X; Zhang S; Zhang D; Lin J; Hasengbayi S; Han W
Cancer Med; 2019 Nov; 8(15):6756-6767. PubMed ID: 31503422
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of Dickkopf-1 predicts poor prognosis for patients with hepatocellular carcinoma after orthotopic liver transplantation by promoting cancer metastasis and recurrence.
Huang Y; Yang X; Zhao F; Shen Q; Wang Z; Lv X; Hu B; Yu B; Fan J; Qin W
Med Oncol; 2014 Jul; 31(7):966. PubMed ID: 24878698
[TBL] [Abstract][Full Text] [Related]
14. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
15. High expression of microRNA-130b correlates with poor prognosis of patients with hepatocellular carcinoma.
Wang WY; Zhang HF; Wang L; Ma YP; Gao F; Zhang SJ; Wang LC
Diagn Pathol; 2014 Aug; 9():160. PubMed ID: 25123453
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of miR-3607 predicts prognosis of hepatocellular carcinoma and regulates tumor cell proliferation, migration and invasion.
Dou W; Yang M; Su Y; Xie R
Diagn Pathol; 2020 May; 15(1):54. PubMed ID: 32404179
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic role of microRNA-423-5p in hepatocellular carcinoma.
Wu LM; Ji JS; Yang Z; Xing CY; Pan TT; Xie HY; Zhang F; Zhuang L; Zhou L; Zheng SS
Hepatobiliary Pancreat Dis Int; 2015 Dec; 14(6):613-8. PubMed ID: 26663009
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
[TBL] [Abstract][Full Text] [Related]
19. miR-744 is a potential prognostic marker in patients with hepatocellular carcinoma.
Tan YL; Bai ZG; Zou WL; Ma XM; Wang TT; Guo W; Liu J; Li JS; Jie-Yin ; Zang YJ; Zhang ZT
Clin Res Hepatol Gastroenterol; 2015 Jun; 39(3):359-65. PubMed ID: 25543521
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA associated with microvascular invasion in hepatocellular carcinoma promotes angiogenesis and serves as a predictor for hepatocellular carcinoma patients' poor recurrence-free survival after hepatectomy.
Yuan SX; Yang F; Yang Y; Tao QF; Zhang J; Huang G; Yang Y; Wang RY; Yang S; Huo XS; Zhang L; Wang F; Sun SH; Zhou WP
Hepatology; 2012 Dec; 56(6):2231-41. PubMed ID: 22706893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]